NEW JERSEY STEM CELL RESEARCH

Brand Owner (click to sort) Address Description
NJSCREF The New Jersey Stem Cell Research Endowment Fund Inc. PO Box 2926 Westfield NJ 07091 NEW JERSEY STEM CELL RESEARCH ENDOWMENT FUND;Licensing of stem cell research technology, namely, the business of developing and managing transactions involving stem cells and/or stem cell-related technology, products, processes, services, systems, information and know-how;
NJSCREF The New Jersey Stem Cell Research Endowment Fund Inc. PO Box 2926 Westfield NJ 07091 NEW JERSEY STEM CELL RESEARCH ENDOWMENT FUND;Providing scientific, technical, and medical information and scientific, technical, and medical research assistance in the field of stem cell research; scientific research in the field of stem cells; medical services, namely, laboratory and clinical research in the field of stems cells, their clinical use and application, and their potential commercialization and use in patient care; producing stem cells and differentiated cell types, embryonic stem cell lines, transgenic animals and proteins for research, medical use and pharmaceutical development by others; providing technical and scientific information concerning stem cell research; collection and dissemination of information concerning current events and issues relating to stem cell research; providing medical, scientific, clinical, and research information, including electronically and via the Internet, in the field of stem cell research and clinical and commercial applications of stem cell research for audiences including, but not limited to, schools, medical, graduate, veterinary and agricultural programs, physicians and physician groups, hospitals, healthcare centers, payers and providers, trade groups and associations, private and public enterprises and the general public;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. A method of ex-vivo expanding a population of stem cells, while at the same time inhibiting differentiation of the stem cells. The method comprises ex-vivo providing the stem cells with conditions for cell proliferation and with at least one copper chelator in an amount and for a time period for permitting the stem cells to proliferate and, at the same time, for reducing a capacity of the stem cells to differentiate